Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 2 of 3: Mean cell count and mean normalized growth rate inhibition values across all replicates. - Dataset (ID:20257)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | PLX-4720 | 10 | uM | 3 | 2500.00 | 2418.67 | 4495.00 | 4525.50 | 0.9937 | 0.9874 |
| SK-BR-3 | PLX-4720 | 19.9526 | uM | 3 | 2500.00 | 2418.67 | 4184.33 | 4525.50 | 0.9248 | 0.8346 |
| SK-BR-3 | NVP-TAE684 | 0.0016596 | uM | 3 | 2500.00 | 2418.67 | 4679.33 | 4525.50 | 1.0339 | 1.0747 |
| SK-BR-3 | NVP-TAE684 | 0.0033113 | uM | 3 | 2500.00 | 2418.67 | 4648.67 | 4525.50 | 1.0274 | 1.0613 |
| SK-BR-3 | NVP-TAE684 | 0.01 | uM | 3 | 2500.00 | 2418.67 | 4599.33 | 4525.50 | 1.0164 | 1.0365 |
| SK-BR-3 | NVP-TAE684 | 0.031623 | uM | 3 | 2500.00 | 2418.67 | 4391.33 | 4525.50 | 0.9705 | 0.9355 |
| SK-BR-3 | NVP-TAE684 | 0.1 | uM | 3 | 2500.00 | 2418.67 | 4620.00 | 4525.50 | 1.0206 | 1.0446 |
| SK-BR-3 | NVP-TAE684 | 0.31623 | uM | 3 | 2500.00 | 2418.67 | 4507.00 | 4525.50 | 0.9959 | 0.9907 |
| SK-BR-3 | NVP-TAE684 | 1 | uM | 3 | 2500.00 | 2418.67 | 4173.00 | 4525.50 | 0.9226 | 0.8314 |
| SK-BR-3 | NVP-TAE684 | 3.1623 | uM | 3 | 2500.00 | 2418.67 | 2188.67 | 4525.50 | 0.4835 | -0.1052 |
| SK-BR-3 | NVP-TAE684 | 10 | uM | 3 | 2500.00 | 2418.67 | 1901.00 | 4525.50 | 0.4202 | -0.2339 |
| SK-BR-3 | Palbociclib | 0.0033113 | uM | 3 | 2500.00 | 2418.67 | 3905.00 | 4308.42 | 0.9062 | 0.7769 |
| SK-BR-3 | Palbociclib | 0.01 | uM | 3 | 2500.00 | 2418.67 | 4211.67 | 4308.42 | 0.9775 | 0.9461 |
| SK-BR-3 | Palbociclib | 0.031623 | uM | 3 | 2500.00 | 2418.67 | 3786.00 | 4308.42 | 0.8786 | 0.7113 |
| SK-BR-3 | Palbociclib | 0.1 | uM | 3 | 2500.00 | 2418.67 | 3791.00 | 4308.42 | 0.8795 | 0.7132 |
| SK-BR-3 | Palbociclib | 0.31623 | uM | 3 | 2500.00 | 2418.67 | 3273.00 | 4308.42 | 0.7592 | 0.4356 |
| SK-BR-3 | Palbociclib | 1 | uM | 3 | 2500.00 | 2418.67 | 3111.00 | 4308.42 | 0.7219 | 0.3518 |
| SK-BR-3 | Palbociclib | 3.1623 | uM | 3 | 2500.00 | 2418.67 | 3185.33 | 4308.42 | 0.7393 | 0.3911 |
| SK-BR-3 | Palbociclib | 10 | uM | 3 | 2500.00 | 2418.67 | 2603.33 | 4308.42 | 0.6040 | 0.0913 |
| SK-BR-3 | Palbociclib | 19.9526 | uM | 3 | 2500.00 | 2418.67 | 2581.33 | 4308.42 | 0.5984 | 0.0803 |
| SK-BR-3 | Omipalisib | 0.0016596 | uM | 3 | 5000.00 | 4101.40 | 5057.00 | 5695.67 | 0.8872 | 0.5355 |
| SK-BR-3 | Omipalisib | 0.0033113 | uM | 3 | 5000.00 | 4101.40 | 4599.33 | 5695.67 | 0.8072 | 0.2553 |
| SK-BR-3 | Omipalisib | 0.01 | uM | 3 | 5000.00 | 4101.40 | 3864.33 | 5695.67 | 0.6761 | -0.1353 |
| SK-BR-3 | Omipalisib | 0.031623 | uM | 3 | 5000.00 | 4101.40 | 3243.67 | 5695.67 | 0.5687 | -0.4007 |
| SK-BR-3 | Omipalisib | 0.1 | uM | 3 | 5000.00 | 4101.40 | 2700.33 | 5695.67 | 0.4732 | -0.5889 |